×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.27 B
Last 13-F Filed: Q1 2024
Concentration in top 10: 71.44%
Filter by:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
AVDLAvadel Pharmaceuticals PLC5.27%3,972,099$67,088,752-124,329-3.04%$16.8913F
VRNAVerona Pharma PLC4.56%3,610,177$58,087,748-639,741-15.05%$16.0913F
ATXSAstria Therapeutics Inc2.58%2,329,027$32,781,055-153,700-6.19%$14.0713F
ALPNAlpine Immune Sciences Inc1.63%520,505$20,794,175-298,770-36.47%$39.9513F
TARSTarsus Pharmaceuticals Inc1.62%565,550$20,557,743-1,218,456-68.3%$36.3513F
RZLTRezolute Inc0.56%2,797,704$7,134,145-445,138-13.73%$2.5513F
TILInstil Bio Inc0.53%624,338$6,742,850-2-0.00032%$10.813F